<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">However, their application has been restricted by the instability and inefficient 
 <italic>in vivo</italic> delivery of nucleic acid (DNA or mRNA)
 <xref rid="bib67" ref-type="bibr">
  <sup>67</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib68" ref-type="bibr">
  <sup>68</sup>
 </xref>. To provide protection from degradation and facilitate their entry into targeted cells, efficient delivery systems for nucleic acid vaccines, particularly the nanocarriers, have been explored extensively.
</p>
